M. D. ARPA Et Al. , "Chitosan-based buccal mucoadhesive bilayer tablets enhance the bioavailability of tizanidine hydrochloride by bypassing the first-pass metabolism," Journal of Drug Delivery Science and Technology , vol.97, 2024
ARPA, M. D. Et Al. 2024. Chitosan-based buccal mucoadhesive bilayer tablets enhance the bioavailability of tizanidine hydrochloride by bypassing the first-pass metabolism. Journal of Drug Delivery Science and Technology , vol.97 .
ARPA, M. D., Okur, N. Ü., GÖK, M. K., & CEVHER, E., (2024). Chitosan-based buccal mucoadhesive bilayer tablets enhance the bioavailability of tizanidine hydrochloride by bypassing the first-pass metabolism. Journal of Drug Delivery Science and Technology , vol.97.
ARPA, Muhammet Et Al. "Chitosan-based buccal mucoadhesive bilayer tablets enhance the bioavailability of tizanidine hydrochloride by bypassing the first-pass metabolism," Journal of Drug Delivery Science and Technology , vol.97, 2024
ARPA, Muhammet D. Et Al. "Chitosan-based buccal mucoadhesive bilayer tablets enhance the bioavailability of tizanidine hydrochloride by bypassing the first-pass metabolism." Journal of Drug Delivery Science and Technology , vol.97, 2024
ARPA, M. D. Et Al. (2024) . "Chitosan-based buccal mucoadhesive bilayer tablets enhance the bioavailability of tizanidine hydrochloride by bypassing the first-pass metabolism." Journal of Drug Delivery Science and Technology , vol.97.
@article{article, author={Muhammet Davut ARPA Et Al. }, title={Chitosan-based buccal mucoadhesive bilayer tablets enhance the bioavailability of tizanidine hydrochloride by bypassing the first-pass metabolism}, journal={Journal of Drug Delivery Science and Technology}, year=2024}